London Partner Roberta Downey Wired for Disputes: Tech, Infrastructure, and the New Frontier of Risk
Law School Toolbox Podcast Episode 505: Breaking ADHD Barriers with the Help of AI (w/Lindsay Scola)
No Password Required: CEO of HACKERverse.ai, Disruptor of Cybersecurity Sales and Most Other Things
(Podcast) The Briefing: No CTRL-ALT-DEL For the Server Test
Compliance Tip of the Day – Role of Chatbots in Compliance
5 Key Takeaways | AI and Your Patent Management, Strategy & Portfolio
(Podcast) The Briefing: The Future of TV? A 2025 Digital Media Trends Analysis
The Privacy Insider Podcast Episode 13: Preserving Privacy and Social Connection with Christine Rosen of the American Enterprise Institute
Great Women in Compliance: Creating Space to Speak Up: The Story Behind Psst.org
JONES DAY TALKS®: Women in IP – AI and Copyright Law Need-to-Knows
No Password Required: SVP at SpyCloud Labs, Former Army Investigator, and Current Breakfast Champion
Compliance into the Weeds: The Role of Compliance Going Forward
A Less is More Strategy for Data Risk Mitigation
Third-Party Risk The competitive world of banking struggles to keep up with technological advances, particularly in a regulatory environment.
Investment Opportunities in Italy's Tech Market
The AI Shakeup: New Tech Innovations and the Future of Corporate Law
Regulatory Ramblings: Episode 44 - The Dangers of Non-Technically Trained Lawyers Advising on Technological Matters with Ronald Yu and Donald Day
[Webinar] AI and Data Privacy: Minimizing Risk and Maximizing Opportunity
Tips and Trends in Thought-Leadership Marketing
Guidepost in Motion EP27: Privacy Matters Part 2: “TMI”-The Privacy Dilemma of Social Media
Key Points - - Who is impacted: Manufacturers of pharmaceutical, biotechnology, medical device and food products. - What is changing: The agency is prioritizing user fee reauthorization, the MAHA initiative and a push for...more
M&A in the AI sector is redefining deal risk, especially when sensitive data is involved. As AI companies power breakthroughs in biotech, healthcare, defense, and critical infrastructure, the stakes for companies acquiring...more
Private Equity focused on investment and operations within the Life Science industry faces significant compliance, operational and business risk due to the heavily regulated nature of the investment targets and portfolio...more
Early in the new year, the US Food and Drug Administration (FDA) released two anticipated draft guidance documents focused on artificial intelligence (AI): Artificial Intelligence-Enabled Device Software Functions: Lifecycle...more
The food, drug and medical device industries comprise some of the most closely regulated sectors in the United States. The US Food & Drug Administration (FDA) actively exercises authority by constantly changing legislation...more
The Food and Drug Administration (FDA) is seeking strategies from Jeffrey W. Taub, M.D., to prevent future violations of human subject regulations the agency said were documented during site visits in September and October...more